A systematic review and meta-analysis found that diabetic foot ulcers substantially impair patient quality of life, driven by pain, wound severity, and psychological distress. The synthesis consolidates observational evidence across multiple studies to quantify the magnitude of harm beyond clinical outcomes. Complementing the patient-centered signal, another clinical study identified a miRNA–ferroptosis-linked axis associated with diabetic foot ulcer progression. In a cross-sectional human cohort of 320 subjects, circulating miR-324-3p increased progressively from healthy controls to uncomplicated type 2 diabetes and peaked in active ulcers, while serum GPX4 activity decreased—supporting an inverse relationship tied to inflammatory markers. Together, the two papers connect lived burden with mechanistic biomarkers, strengthening the rationale for therapies that address both ulcer biology and quality-of-life endpoints in future interventional studies.
Get the Daily Brief